Close Menu

Life Bioscience

Sony of Tokyo has received US Patent No.

Luminex President and CEO Patrick Balthrop has been elected to the Personalized Medicine Coalition's board of directors for a three-year term.

The firm's new Oracle 3D glass nanowell microarray substrates are targeted towards customers that use protein arrays for research, in drug discovery, and, potentially, in the clinic.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.